Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2018 1
2020 2
2021 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Genome-Editing Technologies: Principles and Applications.
Gaj T, Sirk SJ, Shui SL, Liu J. Gaj T, et al. Cold Spring Harb Perspect Biol. 2016 Dec 1;8(12):a023754. doi: 10.1101/cshperspect.a023754. Cold Spring Harb Perspect Biol. 2016. PMID: 27908936 Free PMC article. Review.
Rational Design of Chemically Controlled Antibodies and Protein Therapeutics.
Marchand A, Bonati L, Shui S, Scheller L, Gainza P, Rosset S, Georgeon S, Tang L, Correia BE. Marchand A, et al. Among authors: shui s. ACS Chem Biol. 2023 Jun 16;18(6):1259-1265. doi: 10.1021/acschembio.3c00012. Epub 2023 May 30. ACS Chem Biol. 2023. PMID: 37252896 Free PMC article.
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy.
Giordano-Attianese G, Gainza P, Gray-Gaillard E, Cribioli E, Shui S, Kim S, Kwak MJ, Vollers S, Corria Osorio AJ, Reichenbach P, Bonet J, Oh BH, Irving M, Coukos G, Correia BE. Giordano-Attianese G, et al. Among authors: shui s. Nat Biotechnol. 2020 Apr;38(4):426-432. doi: 10.1038/s41587-019-0403-9. Epub 2020 Feb 3. Nat Biotechnol. 2020. PMID: 32015549
Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy.
Giordano-Attianese G, Gainza P, Gray-Gaillard E, Cribioli E, Shui S, Kim S, Kwak MJ, Vollers S, Corria Osorio AJ, Reichenbach P, Bonet J, Oh BH, Irving M, Coukos G, Correia BE. Giordano-Attianese G, et al. Among authors: shui s. Nat Biotechnol. 2020 Apr;38(4):503. doi: 10.1038/s41587-020-0461-z. Nat Biotechnol. 2020. PMID: 32127717
12 results